Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual vs Subcutaneous Immunotherapy in Asthma
NCT05786638Completed
- Sponsor
- Mansoura University Hospital
- Start
- Oct 2021
- Primary completion
- Oct 2022
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of Allergen Immunotherapy Extract in allergic asthma (2 arms), sponsored by Mansoura University Hospital. Primary endpoints: Total Immunoglobulin E at 18 months and Sputum Eosinophil Count at 18 months. Started Oct 2021; status: completed.
02
Drugs
Allergen Immunotherapy Extract
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT05786638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05786638.